Tony Gibson

631 total citations
21 papers, 466 citations indexed

About

Tony Gibson is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Tony Gibson has authored 21 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Pharmaceutical Science. Recurrent topics in Tony Gibson's work include Chemical Reactions and Isotopes (5 papers), Chemical Synthesis and Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Tony Gibson is often cited by papers focused on Chemical Reactions and Isotopes (5 papers), Chemical Synthesis and Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Tony Gibson collaborates with scholars based in United States, China and Japan. Tony Gibson's co-authors include Qun Dang, Paul D. van Poelje, Mark D. Erion, Scott Potter, Yan Liu, Srinivas Rao Kasibhatla, Jonathan Z. Ho, J. Edward Semple, Tao Jiang and Zhili Sun and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Gastroenterology and Tetrahedron Letters.

In The Last Decade

Tony Gibson

21 papers receiving 441 citations

Peers

Tony Gibson
Dmitry Borkin United States
Allyn T. Londregan United States
Ramzi F. Sweis United States
John L. Gilmore United States
Mark A. Zottola United States
Manus Ipek United States
Matthew M. Weiss United States
Xiaolun Wang United States
Patrick Angibaud France
Peter H. Fuller United States
Dmitry Borkin United States
Tony Gibson
Citations per year, relative to Tony Gibson Tony Gibson (= 1×) peers Dmitry Borkin

Countries citing papers authored by Tony Gibson

Since Specialization
Citations

This map shows the geographic impact of Tony Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Gibson more than expected).

Fields of papers citing papers by Tony Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Gibson. The network helps show where Tony Gibson may publish in the future.

Co-authorship network of co-authors of Tony Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Gibson. A scholar is included among the top collaborators of Tony Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Gibson. Tony Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
France, Scott P., Erick A. Lindsey, Emma L. McInturff, et al.. (2025). Synthetic Approaches to the New Drugs Approved during 2023. Journal of Medicinal Chemistry. 68(3). 2147–2182. 2 indexed citations
2.
Tafi, Rosalba, Ruhi Kamran, Tony Gibson, et al.. (2024). De novo discovery of cyclic peptide inhibitors of IL-11 signaling. Bioorganic & Medicinal Chemistry. 119. 118017–118017. 1 indexed citations
3.
France, Scott P., Erick A. Lindsey, Emma L. McInturff, et al.. (2024). Synthetic Approaches to the New Drugs Approved During 2022. Journal of Medicinal Chemistry. 67(6). 4376–4418. 15 indexed citations
4.
McInturff, Emma L., Scott P. France, Carolyn A. Leverett, et al.. (2023). Synthetic Approaches to the New Drugs Approved During 2021. Journal of Medicinal Chemistry. 66(15). 10150–10201. 14 indexed citations
5.
Flick, Andrew C., Carolyn A. Leverett, Hong X. Ding, et al.. (2022). Synthetic Approaches to the New Drugs Approved During 2020. Journal of Medicinal Chemistry. 65(14). 9607–9661. 24 indexed citations
6.
Flick, Andrew C., Carolyn A. Leverett, Hong X. Ding, et al.. (2021). Synthetic Approaches to the New Drugs Approved during 2019. Journal of Medicinal Chemistry. 64(7). 3604–3657. 33 indexed citations
7.
Gibson, Tony, et al.. (2017). Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorganic & Medicinal Chemistry Letters. 27(8). 1709–1713. 15 indexed citations
8.
Lanier, Marion, Erica L. Bradshaw‐Pierce, Alison Chambers, et al.. (2017). Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure. ACS Medicinal Chemistry Letters. 8(3). 316–320. 33 indexed citations
9.
Dang, Qun, Tao Jiang, Tony Gibson, et al.. (2011). Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity. MedChemComm. 2(4). 287–290. 16 indexed citations
10.
Dang, Qun, Yan Liu, Daniel K. Cashion, et al.. (2010). Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase. Journal of Medicinal Chemistry. 54(1). 153–165. 141 indexed citations
11.
12.
Dang, Qun, et al.. (2009). A tandem decarboxylation and inverse electron-demand Diels–Alder reaction of amino-thiophenecarboxylic acids with 1,3,5-triazines. Tetrahedron Letters. 50(24). 2874–2876. 12 indexed citations
13.
Pascoe, Sean & Tony Gibson. (2008). Do boat licences have a role in fisheries managed through individual quotas? Experience in Australian fisheries. Marine Policy. 33(2). 297–304. 2 indexed citations
14.
Reiner, John, Daniel V. Siev, Jingrong Jean Cui, et al.. (2002). Non-covalent thrombin inhibitors featuring p3-heterocycles with P1-monocyclic arginine surrogates. Bioorganic & Medicinal Chemistry Letters. 12(8). 1203–1208. 25 indexed citations
15.
Ho, Jonathan Z., Tony Gibson, & J. Edward Semple. (2002). Novel, Potent Non-Covalent Thrombin Inhibitors Incorporating P3-Lactam Scaffolds. Bioorganic & Medicinal Chemistry Letters. 12(5). 743–748. 25 indexed citations
16.
Cui, Jingrong Jean, John Reiner, Komandla Malla Reddy, et al.. (2002). Non-covalent thrombin inhibitors featuring P3-Heterocycles with P1-Bicyclic arginine surrogates. Bioorganic & Medicinal Chemistry Letters. 12(20). 2925–2930. 18 indexed citations
17.
Gibson, Tony. (2000). Esophageal adhesion of risedronate and alendronate tablets in isolated porcine esophagus. The American Journal of Gastroenterology. 95(9). 2421–2421. 1 indexed citations
18.
Ho, Jonathan Z., et al.. (1999). Exploratory solid-phase synthesis of factor Xa inhibitors: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates. Bioorganic & Medicinal Chemistry Letters. 9(24). 3459–3464. 4 indexed citations
19.
Theodorakis, Emmanuel A., Xin Xiang, Mindo Lee, & Tony Gibson. (1998). On the mechanism of photo-induced nucleic acid cleavage using N-aroyloxy-2-thiopyridones. Tetrahedron Letters. 39(21). 3383–3386. 11 indexed citations
20.
Gibson, Tony. (1986). Decision-making in neighbourhood design and development. Design Studies. 7(3). 163–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dmitry Borkin Breakdown of academic impact, for papers by Allyn T. Londregan Breakdown of academic impact, for papers by Ramzi F. Sweis Breakdown of academic impact, for papers by John L. Gilmore Breakdown of academic impact, for papers by Mark A. Zottola Breakdown of academic impact, for papers by Manus Ipek Breakdown of academic impact, for papers by Matthew M. Weiss Breakdown of academic impact, for papers by Xiaolun Wang Breakdown of academic impact, for papers by Patrick Angibaud Breakdown of academic impact, for papers by Peter H. Fuller
Rankless by CCL
2026